{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:52:20Z","timestamp":1790099540585,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002724","name":"American University of Sharjah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejmg.2022.104456","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T04:02:42Z","timestamp":1645588962000},"page":"104456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Methylation analysis and developmental profile of two individuals with Angelman syndrome due to mosaic imprinting defects"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1165-0490","authenticated-orcid":false,"given":"Emma K.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-3132","authenticated-orcid":false,"given":"Catherine F.","family":"Merton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1593-6149","authenticated-orcid":false,"given":"Wen-Hann","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Dudding-Byth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Godler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejmg.2022.104456_bib1","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am. J. Ment. Defic."},{"key":"10.1016\/j.ejmg.2022.104456_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.comppsych.2014.12.005","article-title":"A disease specific questionnaire for assessing behavior in individuals with Prader\u2013Willi syndrome","volume":"58","author":"Avrahamy","year":"2014","journal-title":"Compr. Psychiatr."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104456_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13039-016-0233-0","article-title":"Patients with mosaic methylation patterns of the Prader-Willi\/Angelman Syndrome critical region exhibit AS-like phenotypes with some PWS features","volume":"9","author":"Aypar","year":"2016","journal-title":"Mol. Cytogenet."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104456_bib4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41398-020-01034-7","article-title":"Relationships between UBE3A and SNORD116 expression and features of autism in chromosome 15 imprinting disorders","volume":"10","author":"Baker","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejmg.2022.104456_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/TACG.S57386","article-title":"Angelman syndrome: review of clinical and molecular aspects","volume":"7","author":"Bird","year":"2014","journal-title":"Appl. Clin. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2022.104456_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.c.30273","article-title":"Prader\u2013willi syndrome and Angelman syndrome","volume":"154C","author":"Buiting","year":"2010","journal-title":"Am. J. Med. Genet. Part C, Seminars in medical genetics"},{"issue":"3","key":"10.1016\/j.ejmg.2022.104456_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/367926","article-title":"Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect","volume":"72","author":"Buiting","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.ejmg.2022.104456_bib8","article-title":"Preserved expressive language as a phenotypic determinant of Mosaic Angelman Syndrome","volume":"7","author":"Carson","year":"2019","journal-title":"Mol. Gene. Genom. Med."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104456_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ajmg.a.61940","article-title":"Clinical aspects of a large group of adults with Angelman syndrome","volume":"185","author":"Den Besten","year":"2021","journal-title":"Am. J. Med. Genet."},{"issue":"7","key":"10.1016\/j.ejmg.2022.104456_bib10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ajmg.a.37058","article-title":"Mild Angelman syndrome phenotype due to a mosaic methylation imprinting defect","volume":"167","author":"Fairbrother","year":"2015","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2022.104456_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.ejhg.5200362","article-title":"A previously unrecognised phenotype characterised by obesity, muscular hypotonia, and ability to speak in patients with Angelman syndrome caused by an imprinting defect","volume":"7","author":"Gillessen-Kaesbach","year":"1999","journal-title":"Eur. J. Hum. Genet. : EJHG (Eur. J. Hum. Genet.)"},{"issue":"8","key":"10.1016\/j.ejmg.2022.104456_bib12","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/hmg\/ddt002","article-title":"Relationships between age and epi-genotype of the FMR1 exon 1\/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty","volume":"22","author":"Godler","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104456_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.41911","article-title":"Feasibility of screening for chromosome 15 imprinting disorders in 16 579 newborns by using a novel genomic workflow","volume":"5","author":"Godler","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.ejmg.2022.104456_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ajmg.a.38072","article-title":"Atypical Angelman syndrome due to a mosaic imprinting defect: Case reports and review of the literature","volume":"173","author":"Le Fevre","year":"2017","journal-title":"Am. J. Med. Genet."},{"issue":"21","key":"10.1016\/j.ejmg.2022.104456_bib15","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/hmg\/ddh296","article-title":"Somatic mosaicism in patients with Angelman syndrome and an imprinting defect","volume":"13","author":"Nazlican","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2022.104456_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.6000\/2292-2598.2015.03.03.2","article-title":"Somatic mosaicism as modulator of the global and intellectual phenotype in epimutated Angelman syndrome patients","volume":"3","author":"Russo","year":"2015","journal-title":"J. Intellect. Disability - Diagn.Treatment"},{"issue":"6","key":"10.1016\/j.ejmg.2022.104456_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ajmg.a.61140","article-title":"Maladaptive behaviors in individuals with Angelman syndrome","volume":"179","author":"Sadhwani","year":"2019","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2022.104456_bib21","series-title":"Vineland Adaptive Behavior Scales","author":"Sparrow","year":"2016"},{"key":"10.1016\/j.ejmg.2022.104456_bib18","series-title":"Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV)","author":"Wechsler","year":"2008"},{"key":"10.1016\/j.ejmg.2022.104456_bib22","series-title":"Wechsler Abbreviated Scale of Intelligence","author":"Wechsler","year":"2011"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:52:22Z","timestamp":1761709942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721222000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1769721222000374"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104456","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylation analysis and developmental profile of two individuals with Angelman syndrome due to mosaic imprinting defects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104456"}}